Restructuring watch
By BC Staff | Apr 7, 2008 | 7:00 AM GMT
Restructuring watch
| Date | Company | Staff cuts | Cash | Years cash pre-cut | Cash date | Oper loss for 12 mos ended 12/31 |
| 1/15/08 | NitroMed (NASDAQ:NTMD) | 89% to 10 | $31.4 | 0.96 | 12/31/07 | $32.8 |
| Exploring strategic alternatives; discontinuing sales and promotional activities for BiDil, although the fixed-dose combination of hydralazine hydrochloride and disosorbide dinitrate will remain on the market to treat heart failure in black patients |
| 1/21/08 | Curalogic (CSE:CUR) | 50% to 7 | $64.6 | 1.58 | 12/31/07 | $40.8 |
| Aiming to secure a deal this year for new development projects after its ragweed allergy vaccine failed a Phase III trial |
| 1/29/08 | Neose (NASDAQ:NTEC) | 40% to ~30 | $19.3 | 0.52 | 12/31/07 | $37.0 |
|
|
Read the full 1028 word article
